From Anatomy to Electrophysiology: Clinical Lasker Goes Deep
نویسنده
چکیده
This year, the Lasker∼DeBakey Clinical Medical Research Award will be shared by Mahlon R. DeLong and Alim-Louis Benabid for elucidating the role of the subthalamic nucleus in mediating the motor dysfunction of Parkinson's disease and for pioneering the use of deep-brain stimulation to alleviate symptoms of the disease.
منابع مشابه
Discovery of high-frequency deep brain stimulation for treatment of Parkinson disease: 2014 Lasker Award.
The 2014 Lasker-DeBakey Clinical Medical Research Award has been presented toMahlonDeLong,MD, and Alim-Louis Benabid,MD,PhD, to recognizeandhonor themfor theiroutstanding work in the development of high-frequency deep brain stimulation of the subthalamic nucleus for the treatment of patients with advanced Parkinson disease. This Viewpoint provides a summaryof their discoveries in understanding ...
متن کاملArtemisinin: Discovery from the Chinese Herbal Garden
This year's Lasker DeBakey Clinical Research Award goes to Youyou Tu for the discovery of artemisinin and its use in the treatment of malaria--a medical advance that has saved millions of lives across the globe, especially in the developing world.
متن کاملReprogramming to Pluripotency: From Frogs to Stem Cells
This year's Albert Lasker Basic Medical Research Award goes to John Gurdon and Shinya Yamanaka for their contributions to our understanding of how to reprogram adult cells back to early embryonic states.
متن کاملClinical Application of Therapies Targeting VEGF
This year's Lasker DeBakey Clinical Research Award goes to Napoleone Ferrara for the discovery of vascular endothelial growth factor (VEGF) as a major mediator of angiogenesis and for the development of an effective anti-VEGF therapy for wet macular degeneration, a leading cause of blindness in the elderly.
متن کاملReleasing the Brakes on Cancer Immunotherapy
This year's Lasker∼DeBakey Clinical Research Award goes to James Allison for discovering that antibody blockade of the T cell molecule CTLA-4 unleashes the body's immune response against malignant tumors. This has led to development of multiple "immune checkpoint therapies" that are prolonging and saving the lives of thousands of cancer patients.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Cell
دوره 158 شماره
صفحات -
تاریخ انتشار 2014